← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2009First marketed drug
Feb 26, 2020First NDA
Feb 26, 2020Last known activity
Dec 19, 2022
Timeline
2000s
- Jun 1, 2006
Acacia Pharma Ltd— Founded
2020s
- Jul 2, 2020
remimazolam— Marketing Organization
- Jul 2, 2020
remimazolam— NDA Organization
- Jul 2, 2020
remimazolam— NDA Secondary Org
Drugs by trial phase (10 distinct, 17 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (2)
Recent trials (21)
- NCT05546359Lead sponsorPhase 2/Phase 3Dec 19, 2022
- NCT04851717Lead sponsorPhase 2/Phase 3Nov 15, 2021
- NCT04849650Lead sponsorPhase 1Jun 3, 2021
- NCT03583489Lead sponsorPhase 1Jul 17, 2018
- NCT02881840Study directorPhase 1Aug 1, 2016
- NCT02881840Lead sponsorPhase 1Aug 1, 2016
- NCT02646566Lead sponsorPhase 3Mar 1, 2016
- NCT02646566Study directorPhase 3Mar 1, 2016
- NCT02449291Lead sponsorPhase 3Sep 1, 2015
- NCT02337062Lead sponsorPhase 3Feb 1, 2015
- NCT02661594Lead sponsorPhase 1Nov 1, 2013
- NCT02661594Study directorPhase 1Nov 1, 2013
- NCT01857232Lead sponsorPhase 2Oct 1, 2013
- NCT01991860Lead sponsorPhase 3Aug 1, 2013
- NCT01991821Lead sponsorPhase 3Jul 1, 2013
Details
- Founded
- Cambridge, GB Jun 1, 2006
- First NDA
- Feb 26, 2020
- Last known activity
- Dec 19, 2022